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The Phytoestrogen Content of
Rodent Diets
The commentary by Boettger-Tong et al.
(1) described the authors' experience with
a commercially available, unidentified
rodent diet with high estrogenic activity
and the impact of this diet on the normal
in vivo uterotropic response of ovariec-
tomized 30-day-old Sprague-Dawley rats
to exogenously administered estradiol. The
purpose ofthis letter is to corroborate the
authors' findings; to report the phytoestro-
gen content of the rodent diets most fre-
quently used in estrogenicity, toxicity, and
carcinogenicity studies; and to recommend
that careful consideration be given to the
selection of a standardized open-formula
diet, ideally containing minimal or nonde-
tectable levels of estrogenic substances, to
be used in studies that are influenced by
exogenous estrogenic substances. The
authors reported that the lot of feed in
question contained very high amounts of
two well-known phytoestrogens, genistein
(210 mg/kg diet) and daidzein (140
mg/kg), which induced a near maximal
uterotropic response in control rats prior
to hormone treatment. Boettger-Tong et
al. (1) stated that the exact source of the
phytoestrogen contamination in the rodent
diet remains an open question. In our ini-
tial study, we reported that soybean meal
was the major source of daidzein and
genistein in all six natural ingredient
rodent diets assayed and that their concen-
tration was directly correlated with the
soybean meal content in the diets (2).
Three ofthe six natural ingredient diets
assayed contained high total daidzein and
genistein concentrations. Rodent Laboratory
Chow #5001 (Purina Mills, Inc., St. Louis,
MO) contained 277 pg/g daidzein and 214
pg/g genistein (total of491 pg/gdiet). Based
on previous reports (2,3), this is equivalent
to 4.3 ppb of calculated diethylstilbestrol
(DES) activity in this diet. A diet contain-
ing 4 ppb DES induces a significant
increase in the uterine weight/body weight
ratio of immature CD-1 mice fed this diet
for 7 days (4,5). Mouse Chow # 5015
(Purina Mills, Inc.) contained 130 jig/g
daidzein and 97 pg/g genistein (total of
227 pg/g diet); the NIH-07 diet (Zeigler
Brothers, Inc., Gardners, PA) (6) contained
124 ,ug/g daidzein and 104 1ig/g genistein
(total of 228 pg/g diet) as assayed using
high performance liquid chromatography
coupled with mass spectrometry. This is
equivalent to 2.0 ppb DES activity in both
of these diets. Therefore, we agree with
Boettger-Tong et al. (1) that some com-
mercially available rodent diets contain lev-
els of the phytoestrogens daidzein and
genistein that can alter an animal's normal
response to other exogenously administered
estrogens. Some laboratory rodent diets
used in studies evaluating estrogenic sub-
stances, toxicity, or carcinogenicity contain
levels of the phytoestrogens daidzein and
genistein that could alter the results ofthese
studies by binding to estrogen receptor
sites. The estrogenic potential of the phy-
toestrogens has been clearly defined:
Bickoff et al. (3) reported that 8 mg of
genistein or 11 mg of daidzein in 10 g of
diet, consumed over 4-6 days, increased
the uterine weight of immature female
mice from 9.6 mg to 25 mg; Santell et al.
(7) reported that 375 ,ug genistein per gram
of diet induced a significant uterotropic
response in 60-day-old ovariectomized rats.
Most of the research utilizing phytoes-
trogens has explored their potential health
benefits for humans, but fewer studies have
been conducted to determine the dietary
effects of phytoestrogens on rodent estro-
genic or carcinogenesis studies. The effects
of dietary fat, protein, and fiber on mam-
mary tumor incidence and tumor mass were
compared in the TG.NK transgenic mouse
with oncogene c-neu (erb B2). Mice were
fed the AIN-76A casein-based diet (Bio-
Serv, Frenchtown, NJ), the NIH-07 diet, or
the NTP-2000 diet (Zeigler Brothers, Inc.)
for 24 weeks (8). The high fiber content in
the NTP-2000 diet was reported to be pri-
marily responsible for the reduction in
mammary tumors as compared to mice fed
the AIN-76A or the NIH-07 diets. Neither
the phytoestrogen content ofthese diets nor
the effects of dietary phytoestrogens on
mammary tumors in mice used in this study
were reported (8).
The role thatdietaryphytoestrogens play
in induced or spontaneous carcinogenesis in
laboratory animals is unclear. The beneficial
effects of phytoestrogens in animal diets
come from their ability to act as partial
estrogen antagonists (9-414. Animal studies
have shown increased latency and reduced
cancer development with soybean consump-
tion. Feeding a 30% soybean diet to mice
protects the liver from cancer development
induced by the nitrosamine precursors
dibutylamine and nitrite (13). Rats that con-
sumed a soy-based diet developed 40%
fewer mammary tumors following adminis-
tration ofcarcinogens than did rats on asoy-
free diet (14).The phytoestrogens daidzein
and genistein were reported to be responsi-
ble for the reduction in mammarytumors in
these rats (14,15). The incidence ofinduced
prostate-related cancer was reduced and the
disease-free period was prolonged by27% in
Lobund Wistar rats fed a high isoflavone
(genistein, daidzein)-supplemented soy diet
as compared to rats fed thesame soydiet but
with low isoflavone content (16). Also,
neonatal ratsinjectedwithgenistein, allowed
to mature, and then exposed to dimethyl-
benz[a]anthracene to induce mammary car-
cinogenesis had significantly increased laten-
cy in developing tumors as well as reduced
incidence of tumors (15,17). Therefore,
dams consuming diets containing high con-
centrations of estrogenic substances, thus
exposing their pups in utero and prior to
weaning, may alter the pups estrogen
imprinting mechanism or future responses
to other exogenous estrogenic substances
(17). In some tissues this may represent a
protective function, whereas in other tissues
it maybedetrimental.
Significant improvements have been
made in the quality of animal research due
to the use ofdisease-free animals, and recent
advancements have been made through the
development of transgenic mouse models
(18,19). It is important thatproper attention
begiven to the selection and use ofthe most
appropriate diet to achieve theobjective(s) of
a particular study. Improvements have been
made recently in the formulation of diets
used in studies that are influenced by exoge-
nous estrogens. In a secondstudy conducted
by our laboratory (20), some diets from all
major rodent diet vendors, induding three
test diets (4) recently formulated to reduce
the level ofphytoestrogens, AIN-93M (21)
and AIN 76A (22) (Research Diets, Inc.,
NewBrunswick, NJ), with andwithout soy-
beans, HSD Teklad #7012 (Harlan Sprague
Dawley Teklad, Inc., Madison, WI), NIH-
31 (6), NIH-07, and NTP-2000 (23,24),
were compared for phytoestrogen content.
Some diets from all major rodent diet ven-
dors contained high levels ofthephytoestro-
gens daidzein and genistein. The total con-
centration of daidzein and genistein in the
HSD Teklad #7012 diet was 260 pg/g diet.
This is equivalent to 2.3 ppb ofDES activi-
ty. The NIH-31 and the NIH-07 diets con-
tain 5% and 12% soybean meal, respective-
ly, and 4.0 % alfalfa meal; the NTP-2000
diet contains 5% soybean meal and 7.5%
alfalfa meal. The total concentrations of
daidzein and genistein in the NIH-31,
NIH-07, and NTP-2000 diets were 98
pg/g, 176 pg/g, and 95 pg/g, respectively.
This would be equivalent to adding 1.6 ppb
DES to the NIH-07 diet and 0.9 ppb DES
to the NIH-31 and NTP-2000 diets. The
effects that these levels ofdaidzein andgenis-
tein have on results from estrogenicity or
carcinogenicitystuClies are unknown.
We agree with Boettger-Tong et al. (1)
that the levels of the phytoestrogens
induding daidzein and genistein in rodent
diets can vary from batch to batch. The
total isoflavone content in different vari-
eties of soybeans varied from 116 to 309
mg/g and from 46 to 195 mg/g within the
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same variety ofsoybeans grown in different
locations (25,26). Also, in closed formula
diets containing soybeans, the concentra-
tion ofsoybeans in the diet is not reported
and may vary from batch to batch depend-
ing upon the supply and demand ofdietary
ingredients. This could explain why the
phytoestrogen content of diets may vary
greatly from batch to batch or from the
same diet processed by different rodent diet
vendors. These findings support the need
to use open formula diets prepared from
controlled ingredients and the need to
monitor these diets for estrogenic sub-
stances that affect biological end points. We
also agreewith Boettger-Tong et al. (1) that
rodent diet vendors do not routinely moni-
tor all diets for estrogenic substances
including phytoestrogens. Rodent diet ven-
dors producing certified diets for use in
comparative estrogenicity and carcinogenic-
ity studies should provide the user with a
list ofsubstances assayed, including phytoe-
strogens, and the results. In our opinion,
diets used in comparative estrogenicity or
carcinogenicity studies should contain non-
detectable levels of estrogenic substances
that may alter research results. These diets
should be monitored for estrogenic sub-
stances and their concentrations reported.
The commentary by Boettger-Tong et
al. (1) is important because the authors
emphasize the important role of the ani-
mal's diet, especially phytoestrogens, when
conducting animal bioassays for estrogenici-
ty or studies that are influenced by in vivo
end points of hormone action. We previ-
ously reported that rodent diets significantly
differ in estrogenic activity and that a stan-
dardized diet with minimal estrogenic activ-
ity would be desirable for comparative
bioassays for estrogenic substances (5).
Results from our second study (20) confirm
that astandardized open formula diet should
be used for studies that are influenced by
exogenous estrogens (4,5). Phytoestrogens
were not detected in the AIN-76A and the
AIN-93M purified casein diets. Therefore,
careful consideration should be given to the
use of diets such as these when conducting
studies that are influenced by exogenous
estrogens. We have also shown that a natural
ingredient diet can be formulated to contain
less than detectable levels ofthe phytoestro-
gens (daidzein and genistein) by omitting
soybean and alfalfa meals. The soybean and
alfalfa meals were omitted because they may
be a source of multiple, yet unidentified,
phytoestrogens that may further complicate
the interpretation of results from studies
which are influenced by exogenous estro-
gens. We recommend that studies to deter-
mine the effects ofdietary phytoestrogens on
results of toxicloOgiC investigations are
important and timely. National Toxicology
Program studies that will help us understand
the effect oflong-term feeding ofa diet with
less than detectable levels of daidzein and
genistein are presendy underway.
In conclusion, we recommend that
careful consideration be given to the phy-
toestrogen content of the diet when con-
ducting studies that are influenced by
exogenous estrogens. A standardized open
formula diet in which estrogenic substances
have been reduced to minimal levels or to
less than detectable levels of daidzein and
genistein is recommended for use in such
studies. In addition, the selected diet should
be monitored for estrogenic substances, and
their concentrations should be reported.
Julius E. Thigpen
Kenneth D. R. Setchell
Mary F. Goelz
Diane B. Forsythe
NIEHS
Research Triangle Park, North Carolina
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The TEF Approach for
Hexachlorobenzene
Van Birgelen (1) argues that hexachloroben-
zene (HCB) has dioxinlike activity to the
extent that its toxicity may be evaluated
using a so-called toxic equivalency factor
(TEF), which treats the toxic potency of
HCB as a fraction ofthe potency of2,3,7,8-
tetrachloro-p-dibenzodioxin (TCDD). She
suggests a TEF of0.0001 based on compar-
isons of in vitro effects including binding
affinity for the aryl hydrocarbon (Ah) recep-
tor and effective concentrations for
ethoxyresorufin O-dethylase induction and
uroporphyrin accumulation in chicken
hepatocytes. Van Birgelen (1) reported that
these measures were used because "no in
vivo studies designed for estimating a TEF
value are available." This may come as
something ofa surprise to researchers at the
EPA, who derived a potency factor (PF) for
the carcinogenic activity of HCB based on
studies of hepatocellular carcinoma in
female Sprague Dawley rats (2) using a pro-
tocol similar to the one that supports earlier
estimates of the carcinogenic activity of
TCDD (3). The EPA reports that the upper
95th percent confidence bound on the slope
fitting the HCB data to a linearized multi-
stage model ofcarcinogenesis is 1.6 per mil-
ligram of HCB per kilogram body weight
per day (mg/kg/day) (4).
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